HIV virologic response and baseline genotypic resistance in a long-acting cabotegravir/rilpivirine initiation program
Author:
Affiliation:
1. Virginia Commonwealth University School of Pharmacy
2. Department of Pharmacy
3. Division of Infectious Diseases, Virginia Commonwealth University Health System
4. Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Infectious Diseases,Immunology,Immunology and Allergy
Reference11 articles.
1. Perspectives of injectable long acting antiretroviral therapies for HIV treatment or prevention: understanding potential users’ ambivalences;Carillon;AIDS Care,2020
2. Factors associated with interest in a long-acting HIV regimen: perspectives of people living with HIV and healthcare providers in four European countries;Akinwunmi;Sex Transm Infect,2021
3. Long-acting cabotegravir and rilpivirine after oral induction for HIV-1 Infection;Orkin;N Engl J Med,2020
4. Single-center experience evaluating and initiating people with HIV on long-acting cabotegravir/rilpivirine;Hill;AIDS,2023
5. Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2 M), 48-week results: a randomised, multicentre, open-label, phase 3b, noninferiority study;Overton;Lancet,2021
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A6 HIV Subtype in a Pharmacist-Directed Cabotegravir/Rilpivirine Screening Protocol;AIDS Patient Care and STDs;2024-08-22
2. Early Implementation and Outcomes Among People with HIV Who Accessed Long-Acting Injectable Cabotegravir/Rilpivirine at Two Ryan White Clinics in the U.S. South;AIDS Research and Human Retroviruses;2024-07-16
3. A Case of E138K Cabotegravir/Rilpivirine Resistance: Challenges and Concerns When Persons Living With HIV Relocate;Annals of Pharmacotherapy;2024-06-03
4. Patient Attitudes Toward Self- or Partner-, Friend-, or Family-Administered Long-acting Injectable Antiretroviral Therapy: A Mixed-Methods Study Across 3 Urban Human Immunodeficiency Virus Clinics;Open Forum Infectious Diseases;2024-05-13
5. A cautionary note on entry and exit strategies with long-acting cabotegravir and rilpivirine;AIDS;2023-12-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3